MJFF Therapeutics Pipeline Program — Pre-Proposals
Supports Parkinson's disease research teams in the MJFF Therapeutics Pipeline with sustained coaching toward therapeutic candidate development.
The Michael J. Fox Foundation for Parkinson's Research Therapeutics Pipeline Program is one of the largest private grant mechanisms dedicated to advancing disease-modifying and symptomatic interventions for Parkinson's disease. Founded in 2000, MJFF has raised more than $2 billion for Parkinson's research and in 2022 funded more PD research than the U.S. government. The Therapeutics Pipeline Progr…
Pre-clinical and clinical development of disease-modifying or symptomatic interventions for Parkinson's disease, including integration of decision-informing biomarker tools.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see the timeline
Sign up free to see where teams trip up